These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 17143823)

  • 21. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.
    Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):804-9. PubMed ID: 15115092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yield of tuberculin screening among injection drug users.
    Brassard P; Bruneau J; Schwartzman K; Sénécal M; Menzies D
    Int J Tuberc Lung Dis; 2004 Aug; 8(8):988-93. PubMed ID: 15305482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda.
    Moore D; Liechty C; Ekwaru P; Were W; Mwima G; Solberg P; Rutherford G; Mermin J
    AIDS; 2007 Mar; 21(6):713-9. PubMed ID: 17413692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuberculosis case finding and preventive therapy in an HIV voluntary counseling and testing center in Uganda.
    Mugisha B; Bock N; Mermin J; Odeke RM; Miller B; Adatu-Engwau F; Granich R; Bunnell R
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):761-7. PubMed ID: 16848338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results and significance of a baseline tuberculin skin test programme among health care workers in a hospital setting].
    Gerbaudo L; Violante B
    Med Lav; 2007; 98(3):221-31. PubMed ID: 17598350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
    Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
    HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test.
    Soborg B; Andersen AB; Larsen HK; Weldingh K; Andersen P; Kofoed K; Ravn P
    Scand J Infect Dis; 2007; 39(6-7):554-9. PubMed ID: 17577817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the QuantiFERON-TB Gold test to confirm latent tuberculosis infection in a Canadian tuberculosis clinic.
    Kunimoto D; Der E; Beckon A; Thomas L; Egedahl M; Beatch A; Williams G; Tyrrell G; Ahmed R; Brown N; Long R
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):726-30. PubMed ID: 19460248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients.
    Eleftheriadis T; Tsiaga P; Antoniadi G; Liakopoulos V; Kortsaris A; Giannatos E; Barbutis K; Stefanidis I; Vargemezis V
    Am J Kidney Dis; 2005 Oct; 46(4):706-12. PubMed ID: 16183426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.
    Detjen AK; Keil T; Roll S; Hauer B; Mauch H; Wahn U; Magdorf K
    Clin Infect Dis; 2007 Aug; 45(3):322-8. PubMed ID: 17599309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
    Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM
    J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
    Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
    Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values.
    Cobelens FG; Egwaga SM; van Ginkel T; Muwinge H; Matee MI; Borgdorff MW
    Clin Infect Dis; 2006 Sep; 43(5):634-9. PubMed ID: 16886159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.
    Moreno S; Jarrin I; Iribarren JA; Perez-Elías MJ; Viciana P; Parra-Ruiz J; Gomez-Sirvent JL; Lopez-Aldeguer J; Gutierrez F; Blanco JR; Vidal F; Leal M; Rodríguez Arenas MA; Del Amo J;
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1393-400. PubMed ID: 19017448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
    AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing tuberculosis incidence in HIV-infected patients by tuberculin skin testing, preventive treatment, and antiretroviral therapy.
    Hamlyn E; Childs K; Post FA
    Clin Infect Dis; 2007 May; 44(10):1393-4; author reply 1394-5. PubMed ID: 17443486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.